Evaluation of a Rifapentine-Containing Regimen for Intensive Phase Treatment of Pulmonary TB

Summary

Patients with sputum-positive tuberculosis had similar negative culture rates after 8 weeks of treatment with rifapentine or rifampin, according to results of the TBTC Study 29 [NCT00694629]. By solid media analysis, 91.4% of the rifapentine group and 89.1% of the rifampin group had negative cultures. By liquid media, the negative-culture rates were 74.6% with rifapentine and 70.1% with rifampin.

  • Pulmonary Clinical Trials
  • Lower Respiratory Infections
View Full Text